Objetivo
The current test systems employed by Industry are poorly predictive for Drug induced liver injury (DILI). The ‘MIP-DILI’ project will address this situation by the development of innovative preclinical test systems which are both mechanism-based and of physiological, pharmacological and pathological relevance to DILI in humans. An iterative, tiered approach with respect to test compounds, test systems, bioanalysis and systems analysis will be adopted to evaluate existing models and develop new models that can provide validated test systems with respect to the prediction of specific forms of DILI and further elucidation of mechanisms. The approach will encompass completely characterised cell lines, well-defined and physiologically stable hepatocytes, multi-cell type in vitro models including novel bioreactors, animal models and appropriate ex vivo human cell models. A systematic analysis of data and iteration at each stage will select the ‘best’ cell line, animal model or pathway for further investigation moving from simple systems to more complex models with reference to relevant clinical and preclinical data on the various forms of DILI. Triangulation of human, in vitro and animal data will provide a fundamental understanding of how drugs can harm the liver. It will then be possible to define the application of each particular novel test system in the context of drug development, and its use in the prediction of liabilities associated with the various forms of DILI that occur in man. Just as importantly, the project will define those models that are not appropriate as decision-making tools for the prediction of DILI in man.
The MIP-DILI consortium contains Key Opinion Leaders from academia, the biotechnology sector and the pharmaceutical industry in the fields of drug development, drug metabolism, drug toxicology, drug hypersensitivity, liver immunology, liver cell biology, pharmacogenetics, systems biology and clinical adverse drug reactions.
Ámbito científico
Convocatoria de propuestas
IMI-JU-03-2010
Consulte otros proyectos de esta convocatoria
Régimen de financiación
JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)Coordinador
151 85 Sodertaelje
Suecia
Ver en el mapa
Participantes (27)
L69 7ZX Liverpool
Ver en el mapa
1081 HV Amsterdam
Ver en el mapa
17177 Stockholm
Ver en el mapa
La participación finalizó
53127 Bonn
Ver en el mapa
6726 SZEGED
Ver en el mapa
35065 RENNES CEDEX
Ver en el mapa
1000 Bruxelles
Ver en el mapa
2311 EZ Leiden
Ver en el mapa
413 46 Göteborg
Ver en el mapa
67115 Plobsheim
Ver en el mapa
69120 Heidelberg
Ver en el mapa
79098 Freiburg
Ver en el mapa
La participación finalizó
DD1 5JJ Dundee
Ver en el mapa
65205 Wiesbaden
Ver en el mapa
10154 New York
Ver en el mapa
TW89GS Brentford
Ver en el mapa
92284 Courbevoie
Ver en el mapa
2340 Beerse
Ver en el mapa
2500 Valby
Ver en el mapa
64293 Darmstadt
Ver en el mapa
02200 Espoo
Ver en el mapa
94250 GENTILLY
Ver en el mapa
1070 Bruxelles / Brussel
Ver en el mapa
3584 CS Utrecht
Ver en el mapa
LS11 5PS Leeds
Ver en el mapa
81675 Muenchen
Ver en el mapa
RG21 4FA Basingstoke
Ver en el mapa